Table 3.

Number of weeks that patients adhered to each intervention component during the 56-week IBT program

	Liraglutide 3.0 mg + IBT (n = 142)	Placebo + IBT (n = 140)
Weeks adherent to dietary self-monitoring	38.4 (16.0)	36.1 (17.3)
Weeks adherent to physical activity	29.0 (17.1)	30.0 (17.2)
Weeks adherent to the trial product	49.5 (14.0)	46.8 (16.1)

Data are means (SD). The maximum number of weeks that a participant could have adhered to the intervention was 56 for all treatment components. IBT, intensive behavioral therapy.